Digoxin, a drug derived from the foxglove plant, is one of the oldest and most widely used treatments for a variety of cardiac conditions. For example, it can regularize the heartbeat in many who have ...

LONDON, UK — The use of digoxin was associated with a slightly improved survival but no difference in rate of rehospitalization in a new study based on a nationwide propensity-matched cohort of Danish ...

UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...

Digoxin, a drug commonly used to treat heart conditions, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure. Digoxin, a drug commonly used ...

AHA: Increased Cancer Risk for Patients With Heart Failure Incident digoxin use was linked with higher rates of death and heart failure hospitalization. James V. Freeman, MD, of Stanford University in ...

Oct. 30, 2002 — Digoxin may pose a risk of death for women with heart failure, according to a retrospective analysis published in the Oct. 31 issue of the New England Journal of Medicine. Yet ...

(HealthDay News) — Only 1 in 5 patients with heart failure with reduced ejection fraction (HFrEF) receive digoxin at discharge, according to a study published online in JACC: Heart Failure. Nish Patel ...

At present, digoxin should not be recommended for the treatment of patients with mild-to-moderate diastolic HF with preserved LVEF of greater than 45% in sinus rhythm This was an ancillary study ...

Digoxin 0.25mg/mL; soln for IV or IM inj. Lanoxin (digoxin) Injection, 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL); box of 10 ampules or 10 vials. Lanoxin (digoxin) Injection Pediatric, 100 ...

To the Editor: The report by Rathore et al. (Oct. 31 issue) 1 emphasizes differences according to sex in the outcomes of digoxin therapy in patients with congestive heart failure. Their post hoc ...